BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li L, Shen L, Ma J, Zhou Q, Li M, Wu H, Wei M, Zhang D, Wang T, Qin S, Xing T. Evaluating Distribution and Prognostic Value of New Tumor-Infiltrating Lymphocytes in HCC Based on a scRNA-Seq Study With CIBERSORTx. Front Med (Lausanne) 2020;7:451. [PMID: 33043022 DOI: 10.3389/fmed.2020.00451] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Yao S, Huang Z, Wei C, Wang Y, Xiao H, Chen S, Huang Z. CD79A Work as a Potential Target For The Prognosis of Patients With HNSCC: Analysis of Immune Cell Infiltration In Head and Neck Squamous Cell Carcinoma Based on The CIBERSORTx Deconvolution Algorithm.. [DOI: 10.21203/rs.3.rs-2177047/v1] [Reference Citation Analysis]
2 Hu X, Zhu H, Feng S, Wang C, Ye Y, Xiong X. Transmembrane and coiled-coil domains 3 is a diagnostic biomarker for predicting immune checkpoint blockade efficacy in hepatocellular carcinoma. Front Genet 2022;13:1006357. [DOI: 10.3389/fgene.2022.1006357] [Reference Citation Analysis]
3 Zhou L, Chen G, Liu T, Liu X, Yang C, Jiang J. MJDs family members: Potential prognostic targets and immune-associated biomarkers in hepatocellular carcinoma. Front Genet 2022;13:965805. [DOI: 10.3389/fgene.2022.965805] [Reference Citation Analysis]
4 Hao X, Zheng Z, Liu H, Zhang Y, Kang J, Kong X, Rong D, Sun G, Sun G, Liu L, Yu H, Tang W, Wang X. Inhibition of APOC1 promotes the transformation of M2 into M1 macrophages via the ferroptosis pathway and enhances anti-PD1 immunotherapy in hepatocellular carcinoma based on single-cell RNA sequencing. Redox Biology 2022. [DOI: 10.1016/j.redox.2022.102463] [Reference Citation Analysis]
5 Jin X, Hu Z, Sui Q, Zhao M, Liang J, Liao Z, Zheng Y, Wang H, Shi Y, Yu X. A Novel Prognostic Signature Revealed the Interaction of Immune Cells in Tumor Microenvironment Based on Single-Cell RNA Sequencing for Lung Adenocarcinoma. Journal of Immunology Research 2022;2022:1-26. [DOI: 10.1155/2022/6555810] [Reference Citation Analysis]
6 Huang J, Kang W, Pan S, Yu C, Jie Z, Chen C, Ciccarone F. NOL12 as an Oncogenic Biomarker Promotes Hepatocellular Carcinoma Growth and Metastasis. Oxidative Medicine and Cellular Longevity 2022;2022:1-17. [DOI: 10.1155/2022/6891155] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
7 Vadapalli S, Abdelhalim H, Zeeshan S, Ahmed Z. Artificial intelligence and machine learning approaches using gene expression and variant data for personalized medicine. Brief Bioinform 2022:bbac191. [PMID: 35595537 DOI: 10.1093/bib/bbac191] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Wang ZZ, Meng T, Yang MY, Wang W, Zhang Y, Liu Y, Han AQ, Wu J, Wang HX, Qian B, Zhu LX. ALYREF associated with immune infiltration is a prognostic biomarker in hepatocellular carcinoma. Transl Oncol 2022;21:101441. [PMID: 35523010 DOI: 10.1016/j.tranon.2022.101441] [Reference Citation Analysis]
9 Wu X, Zhao X, Xiong Y, Zheng M, Zhong C, Zhou Y. Deciphering Cell-Type-Specific Gene Expression Signatures of Cardiac Diseases Through Reconstruction of Bulk Transcriptomes. Front Cell Dev Biol 2022;10:792774. [DOI: 10.3389/fcell.2022.792774] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Lu J, Chen Y, Zhang X, Guo J, Xu K, Li L. A novel prognostic model based on single-cell RNA sequencing data for hepatocellular carcinoma. Cancer Cell Int 2022;22. [DOI: 10.1186/s12935-022-02469-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
11 Le T, Su S, Shahriyari L. Immune classification of osteosarcoma. Math Biosci Eng 2021;18:1879-97. [PMID: 33757216 DOI: 10.3934/mbe.2021098] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]